Skip to main content

Table 2 Clinical-pathological characteristics of 11 nodal recurrences—institutional endometrial cancer database

From: Associations between lymphovascular space invasion, nodal recurrence, and survival in patients with surgical stage I endometrioid endometrial adenocarcinoma

Nodal recurrence Age Stage Grade LVSI HIR Nodal assessment Adjuvant therapy Nodal recurrence Concurrent recurrence sites
I 57 1B 2 Present Y Pelvic Vaginal brachytherapy Pelvic
II 61 1A 2 Absent N Pelvic Megestrol acetate Pelvic Lungs
III 54 1A 1 Absent N Pelvic None Pelvic Vaginal vault
IV 72 1B 3 Present Y Pelvic and PA Pelvic EBRT Pelvic, para-aortic
V 65 1A 3 Present Y Pelvic and PA None Pelvic Vaginal vault, bone
VI 52 1B 2 Present Y Pelvic None Pelvic
VII 64 1B 2 Present Y Pelvic None Pelvic Vaginal vault
VIII 77 1B 3 Present Y Pelvic and PA Vaginal brachytherapy Pelvic Abdomen
IX 67 1B 3 Present Y Pelvic Pelvic EBRT Mediastinum
X 70 1A 3 Present Y Pelvic Pelvic EBRT Mediastinum Brain
XI 65 1A 3 Present Y Pelvic and PA Chemotherapy Para-aortic Abdomen
  1. LVSI lymphovascular space invasion, HIR high-intermediate risk, Y yes, N no, EBRT external beam radiation therapy, PA para-aortic